Results 1 to 10 of about 17,930 (241)

Meta-analysis of the efficacy and adverse drug reactions of adrenergic alpha-antagonists in treating children with ureteral calculi [PDF]

open access: goldFrontiers in Pediatrics, 2023
This meta-analysis investigated the efficacy and adverse drug reactions (ADRs) of three different adrenergic alpha-antagonists during the treatment of pediatric ureteral stones.
Kai Sun   +5 more
doaj   +6 more sources

Do adrenergic alpha‐antagonists increase the risk of poor cardiovascular outcomes? A systematic review and meta‐analysis [PDF]

open access: goldESC Heart Failure, 2022
Due to concerns regarding neurohormonal activation and fluid retention, adrenergic alpha‐1 receptor antagonists (A1Bs) are generally avoided in the setting of heart disease, namely, symptomatic heart failure (HF) with reduced ejection fraction (HFrEF ...
José Pedro Sousa   +3 more
doaj   +6 more sources

Persistent bothersome urinary frequency following stereotactic body radiation therapy for clinically localized prostate cancer: rationale for prophylactic β3-agonist in men with elevated baseline international prostate symptom scores [PDF]

open access: yesFrontiers in Oncology
IntroductionStereotactic body radiation therapy (SBRT) for clinically localized prostate cancer has been associated with prolonged acute obstructive and irritative lower urinary tract symptoms (LUTS).
Jennifer Zack   +10 more
doaj   +2 more sources

Alpha-adrenergic antagonists and iris dynamics: Challenges and solutions in cataract surgery [PDF]

open access: goldBMC Ophthalmology
Background Alpha-1 adrenergic receptor antagonists (α1-ARAs) are frequently used in treatment of Hypertension and symptomatic benign prostatic hypertrophy (BPH).
Jaya Kaushik   +5 more
doaj   +2 more sources

The use of alpha-adrenergic antagonists in pediatric nephrolithiasis: a systematic review [PDF]

open access: goldFrontiers in Pediatrics
ObjectiveTo evaluate existing clinical evidence for the efficacy of alpha blockers in the management of pediatric stone disease.MethodsWe conducted a systematic review following Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA ...
Firas Haddad   +2 more
doaj   +2 more sources

Medical and non-medical interventions for post-operative urinary retention prevention: network meta-analysis and risk–benefit analysis

open access: yesTherapeutic Advances in Urology, 2021
Aims: To assess the efficacy in lowering post-operative urinary retention, urinary tract infection and lower urinary tract symptoms and the incidence of adverse events among 12 interventions and to perform risk–benefit analysis.
Pokket Sirisreetreerux   +5 more
doaj   +1 more source

Preventive effects of tamsulosin for postoperative urinary retention after lower limb arthroplasty: A randomized controlled study [PDF]

open access: yesInvestigative and Clinical Urology, 2021
Purpose: This prospective, randomized, controlled study investigated the use of tamsulosin, a selective alpha-blocker, as a prophylactic medication to prevent postoperative urinary retention (POUR) following lower limb arthroplasty.
Chang Il Choi   +5 more
doaj   +1 more source

The Noradrenergic System is Partly Involved in Resveratrol Antidepressant and Anti-Obsessive Like Effects in Mice Model [PDF]

open access: yesResearch Journal of Pharmacognosy, 2021
Background and objectives: Resveratrol is a natural phenol in food particularly the skin of fruits like red grapes. It has shown biological, and antidepressant effects.
Azadeh Mesripour*, Fatemeh Payandekhah
doaj   +1 more source

A Prospective, Multicenter, Open-Label Study of Dose Escalation Therapy in Male Patients With Nocturia Refractory to 0.2-mg Tamsulosin Monotherapy [PDF]

open access: yesInternational Neurourology Journal, 2019
Purpose To investigate the efficacy and safety of 0.4 mg of tamsulosin in patients with nocturia not responding to 0.2 mg. Methods Patients with intractable nocturia after treatment with 0.2 mg of tamsulosin for>1 month were included in a multicenter ...
Ho Song Yu   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy